Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Vitamin B6 (in its active form, pyridoxal 5'-phosphate) has been studied for its potential benefits in managing premenstrual syndrome (PMS). Several clinical trials and reviews, including some meta-analyses, have evaluated its role in alleviating PMS symptoms such as mood disturbance, irritability, and fatigue. The rationale for its use is based on B6's involvement in neurotransmitter synthesis (e.g., serotonin and dopamine), which may affect mood regulation during the menstrual cycle.

A 1999 meta-analysis (Wyatt et al., BMJ) reviewed randomized controlled trials and found modest evidence that vitamin B6 supplementation (typically 50-100 mg daily) may reduce overall PMS symptoms compared to placebo. However, the quality of studies was generally low, with small sample sizes and methodological limitations. Later reviews have echoed these findings, suggesting a possible benefit but emphasizing that evidence is not robust or conclusive.

Current clinical guidelines do not uniformly recommend vitamin B6 as a first-line treatment due to inconsistent results and concerns about potential toxicity at higher doses. While some women report subjective improvement, the effect size is generally small, and high-quality, large-scale trials are lacking.

In summary, the use of vitamin B6 for PMS has some scientific grounding, but the evidence is limited and not definitive. It is considered a potential but not strongly validated option for symptom support.

More about Vitamin B6 (pyridoxine 5-phosphate)
More about PMS (general)

Other ingredients used for PMS (general)

Other health conditions supported by Vitamin B6 (pyridoxine 5-phosphate)

Products containing Vitamin B6 (pyridoxine 5-phosphate)